BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $362,000 | -24.3% | 6,713 | -9.8% | 0.02% | -25.0% |
Q2 2022 | $478,000 | +11.2% | 7,440 | +34.2% | 0.03% | +33.3% |
Q1 2022 | $430,000 | -40.9% | 5,544 | -38.6% | 0.02% | -44.7% |
Q3 2021 | $727,000 | -5.3% | 9,031 | -5.4% | 0.04% | +5.6% |
Q2 2021 | $768,000 | +195.4% | 9,546 | +210.1% | 0.04% | +176.9% |
Q1 2021 | $260,000 | +24.4% | 3,078 | +17.9% | 0.01% | -71.7% |
Q4 2020 | $209,000 | -87.7% | 2,610 | -87.6% | 0.05% | -58.2% |
Q3 2020 | $1,696,000 | -33.9% | 21,086 | -29.3% | 0.11% | -34.1% |
Q2 2020 | $2,565,000 | +40.9% | 29,814 | +33.0% | 0.17% | +18.4% |
Q1 2020 | $1,820,000 | +199.3% | 22,412 | +208.5% | 0.14% | +281.1% |
Q4 2019 | $608,000 | -93.4% | 7,265 | -93.1% | 0.04% | -93.9% |
Q3 2019 | $9,175,000 | +100.0% | 104,894 | +87.4% | 0.61% | +90.6% |
Q2 2019 | $4,587,000 | +28.8% | 55,987 | +27.9% | 0.32% | +13.9% |
Q1 2019 | $3,561,000 | -51.5% | 43,790 | -60.7% | 0.28% | -57.1% |
Q4 2018 | $7,341,000 | +9.7% | 111,511 | +28.4% | 0.66% | +30.5% |
Q3 2018 | $6,693,000 | -99.8% | 86,814 | +63.6% | 0.50% | +48.5% |
Q2 2018 | $3,918,984,000 | +153164.9% | 53,074 | +35.0% | 0.34% | +42.6% |
Q1 2018 | $2,557,000 | -55.6% | 39,315 | -55.8% | 0.24% | -51.5% |
Q4 2017 | $5,755,000 | +8.7% | 89,031 | +5.6% | 0.49% | -15.1% |
Q3 2017 | $5,292,000 | -1.8% | 84,338 | -5.2% | 0.58% | +12.3% |
Q2 2017 | $5,387,000 | -16.1% | 88,988 | -28.1% | 0.51% | -10.8% |
Q1 2017 | $6,419,000 | +32.9% | 123,769 | +13.6% | 0.58% | +24.5% |
Q4 2016 | $4,829,000 | +28.2% | 108,923 | +37.6% | 0.46% | +44.4% |
Q3 2016 | $3,767,000 | +132.5% | 79,177 | +121.0% | 0.32% | +110.5% |
Q2 2016 | $1,620,000 | +40.9% | 35,832 | +28.0% | 0.15% | +40.7% |
Q1 2016 | $1,150,000 | -35.6% | 27,996 | -40.2% | 0.11% | -32.9% |
Q4 2015 | $1,786,000 | +304.1% | 46,812 | +247.6% | 0.16% | +274.4% |
Q3 2015 | $442,000 | – | 13,467 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |